Clinical Trial: CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia

U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07201727) titled 'CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia' on Sept. 05.

Brief Summary: This study is a single-arm, open-label, prospective clinical trial, with patients suffering from refractory and relapsed acute myeloid leukemia as the subjects. It plans to enroll 10 cases to evaluate the safety and efficacy of sequential CD123+CLL-1 CAR-T cells followed by CD7 CAR-T cells treatment.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: AML - Acute Myeloid Leukemia

Intervention: BIOLOGICAL: CD123+CLL-1 dual-target CAR-T cells sequential infusion CD...